Pre-Market Movers (Human Genome, Cameco, Barclays, Tata Motors, Cognizant, Banco Santander, Teva Pharma)

Human Genome Sciences, Cameco Corp, Barclays Plc, Tata Motors, Cognizant Technology, Banco Santander, Teva Pharmaceutical Industries and Research In Motion are among the companies whose shares are moving in pre-market trading Monday.

Human Genome Sciences (HGSI) stock surged 3.46 percent to $14.05 in the pre-market trading. Glaxosmithkline Plc is expected to announce an agreement to acquire HGSI for about $2.8 billion as soon as Monday, Reuters reported.

Cameco Corp. (CCJ) stock gained 1.30 percent to $22.60 I pre-market trading. The stock has a 52-week low of $16.59, a 52-week high of $28.68 and $8.82 billion in market capitalization.

Barclays Plc (BCS) stock plunged 4 percent to $9.83 in pre-market trading. The British bank, embroiled in a scandal over Libor rate-fixing, is set to withdraw from a panel that sets benchmark interbank interest rates in the United Arab Emirates, reported the Wall Street Journal, citing two people familiar with the matter.

Tata Motors Ltd. (TTM) stock plunged 3.45 percent to $20.70 in pre-market trading. South Asia’s largest automobile company announced Monday that its group global sales, including Jaguar Land Rover, rose 6 percent to 94,055 vehicles in June on an annual basis.

Cognizant Technology Solutions Corp. (CTSH) stock declined 2.20 percent to $56.00 in pre-market trading. The stock has a 52-week low of $53.54, a 52-week high of $78.00 and $17.44 billion in market capitalization.

Banco Santander S.A. (SAN) stock fell 1.75 percent to $5.63 in pre-market trading. The stock has a 52-week low of $5.19, a 52-week high of $11.50 and $52.01 billion in market capitalization.

Teva Pharmaceutical Industries Ltd. (TEVA) stock fell 1.16 percent to $39.91 in pre-market trading. The company announced Friday that it will release its second quarter 2012 financial results on Thursday, Aug. 2, 2012, at 7:00 a.m. EDT.

Research In Motion Ltd. (RIM) stock declined 0.90 percent to $7.18 in pre-market trading. RIM announced Saturday that it has learned that a jury returned a verdict against RIM in the amount of $147.2 million in an action brought by Mformation in the U.S. District Court for the Northern District of California. The company is disappointed by the outcome and is evaluating all legal options.